Viagra, the brand name for sildenafil, became available as a generic medication in the United States in December 2017. This followed the expiration of Pfizer's patents on the drug.
When Did Generic Viagra Become Available?
Generic sildenafil was launched in the U.S. in December 2017 [1]. Prior to this, Pfizer held exclusive rights to market sildenafil under the brand name Viagra.
Who Makes Generic Viagra?
Following patent expiration, multiple pharmaceutical companies began manufacturing and distributing generic versions of sildenafil. These manufacturers include Teva Pharmaceuticals, Cipla, and others [2].
What is the Difference Between Viagra and Generic Sildenafil?
Generic sildenafil contains the same active ingredient, sildenafil citrate, and is bioequivalent to brand-name Viagra. This means it is absorbed into the bloodstream at the same rate and to the same extent, and therefore produces the same therapeutic effect. Differences may exist in inactive ingredients, such as fillers, binders, and colorings, which do not affect the drug's safety or efficacy [3].
How Much Does Generic Viagra Cost?
The cost of generic sildenafil is typically significantly lower than that of brand-name Viagra. Prices can vary between manufacturers and pharmacies, but the availability of multiple generic options generally leads to increased affordability.
What Are the Patents on Viagra?
Pfizer's primary patents for sildenafil, which protected its formulation and use for erectile dysfunction, expired, allowing for generic entry. The patent landscape for pharmaceuticals can be complex, involving multiple patents covering different aspects of a drug, such as its composition, method of use, and manufacturing [4]. Information on specific patent expirations can be found through resources like DrugPatentWatch.com [5].
What are the Risks of Using Generic Sildenafil?
As generic sildenafil is therapeutically equivalent to Viagra, it carries the same potential side effects and risks. Common side effects include headache, flushing, indigestion, nasal congestion, and visual disturbances. It is important to discuss any concerns with a healthcare provider.
Can Other Companies Challenge Viagra Patents?
Yes, pharmaceutical patent litigation is common. Companies seeking to market generic versions of drugs often challenge existing patents, arguing they are invalid or that their product does not infringe upon them. These challenges can influence the timeline for generic market entry.
---
Sources
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/approved-drug-products-line-extension-patent-and-exclusivity-databases
[2] https://www.drugpatentwatch.com/blog/generic-drug-approvals/
[3] https://www.fda.gov/drugs/generic-drugs/what-you-need-know-about-generic-drugs
[4] https://www.drugpatentwatch.com/blog/understanding-drug-patents/
[5] https://www.drugpatentwatch.com/